32343308|t|Dexmedetomidine with sufentanil in intravenous patient-controlled analgesia for relief from postoperative pain, inflammation and delirium after esophageal cancer surgery.
32343308|a|BACKGROUND AND AIMS: Postoperative pain can cause serious adverse reactions that severely affect postoperative outcome. The present study evaluated the effect of dexmedetomidine (DEX) added to sufentanil in intravenous patient-controlled analgesia (PCA) on the relief of pain and inflammatory responses during postoperative recovery of patients undergoing a combined thoracoscopic-laparoscopic esophagectomy (TLE). METHODS: Sixty patients undergoing TLE were randomly allocated to receive 1 mug/ml of sufentanil alone (Group S) or 1 mug/ml of sufentanil plus 2.5 mug/ml of DEX (Group D) for postoperative intravenous (IV) PCA. Postoperative pain relief, cumulative PCA requirements, inflammatory marker levels, delirium and recovery were assessed. RESULTS: A joint DEX and sufentanil regimen significantly reduced the area under the curve of numerical rating scores for pain at rest (NRSR) and coughing (NRSC) at 1-48 h postoperatively (P = 0.000) that were associated with lower PCA-delivered cumulative sufentanil consumption and less PCA frequency until 48 h postoperatively (P < 0.05 and P < 0.0001, respectively). The simultaneous administration of DEX and sufentanil significantly reduced plasma IL-6 and TNF-alpha concentrations and increased IL-10 level (P < 0.0001, P = 0.0003 and P = 0.0345, respectively), accompanied by better postoperative delirium categories and health statuses of patients (P = 0.024 and P < 0.05, respectively). There was no hypotension, bradycardia, respiratory depression or oversedation in Group D. CONCLUSION: Patients receiving DEX in addition to IV PCA sufentanil for TLE exhibited better postoperative analgesia, fewer inflammatory responses and lower postoperative delirium categories and better health statuses.
32343308	0	15	Dexmedetomidine	Chemical	MESH:D020927
32343308	21	31	sufentanil	Chemical	MESH:D017409
32343308	47	54	patient	Species	9606
32343308	92	110	postoperative pain	Disease	MESH:D010149
32343308	112	124	inflammation	Disease	MESH:D007249
32343308	129	137	delirium	Disease	MESH:D003693
32343308	144	161	esophageal cancer	Disease	MESH:D004938
32343308	192	210	Postoperative pain	Disease	MESH:D010149
32343308	333	348	dexmedetomidine	Chemical	MESH:D020927
32343308	350	353	DEX	Chemical	MESH:D020927
32343308	364	374	sufentanil	Chemical	MESH:D017409
32343308	390	397	patient	Species	9606
32343308	442	446	pain	Disease	MESH:D010146
32343308	451	463	inflammatory	Disease	MESH:D007249
32343308	507	515	patients	Species	9606
32343308	601	609	patients	Species	9606
32343308	672	682	sufentanil	Chemical	MESH:D017409
32343308	714	724	sufentanil	Chemical	MESH:D017409
32343308	744	747	DEX	Chemical	MESH:D020927
32343308	798	816	Postoperative pain	Disease	MESH:D010149
32343308	854	866	inflammatory	Disease	MESH:D007249
32343308	882	890	delirium	Disease	MESH:D003693
32343308	936	939	DEX	Chemical	MESH:D020927
32343308	944	954	sufentanil	Chemical	MESH:D017409
32343308	1041	1045	pain	Disease	MESH:D010146
32343308	1176	1186	sufentanil	Chemical	MESH:D017409
32343308	1325	1328	DEX	Chemical	MESH:D020927
32343308	1333	1343	sufentanil	Chemical	MESH:D017409
32343308	1373	1377	IL-6	Gene	3569
32343308	1382	1391	TNF-alpha	Gene	7124
32343308	1421	1426	IL-10	Gene	3586
32343308	1510	1532	postoperative delirium	Disease	MESH:D000071257
32343308	1567	1575	patients	Species	9606
32343308	1629	1640	hypotension	Disease	MESH:D007022
32343308	1642	1653	bradycardia	Disease	MESH:D001919
32343308	1655	1677	respiratory depression	Disease	MESH:D012131
32343308	1681	1693	oversedation	Disease	
32343308	1718	1726	Patients	Species	9606
32343308	1737	1740	DEX	Chemical	MESH:D020927
32343308	1763	1773	sufentanil	Chemical	MESH:D017409
32343308	1799	1822	postoperative analgesia	Disease	MESH:D000699
32343308	1830	1842	inflammatory	Disease	MESH:D007249
32343308	1863	1885	postoperative delirium	Disease	MESH:D000071257
32343308	Negative_Correlation	MESH:D017409	MESH:D010149
32343308	Negative_Correlation	MESH:D017409	MESH:D003693
32343308	Positive_Correlation	MESH:D017409	3586
32343308	Positive_Correlation	MESH:D020927	3586
32343308	Negative_Correlation	MESH:D020927	MESH:D010146
32343308	Negative_Correlation	MESH:D017409	MESH:D000699
32343308	Negative_Correlation	MESH:D017409	MESH:D020927
32343308	Negative_Correlation	MESH:D017409	MESH:D007249
32343308	Positive_Correlation	MESH:D017409	MESH:D000071257
32343308	Negative_Correlation	MESH:D020927	MESH:D010149
32343308	Negative_Correlation	MESH:D020927	MESH:D003693
32343308	Negative_Correlation	MESH:D020927	MESH:D000071257
32343308	Negative_Correlation	MESH:D017409	7124
32343308	Negative_Correlation	MESH:D020927	3569
32343308	Negative_Correlation	MESH:D020927	MESH:D000699
32343308	Negative_Correlation	MESH:D020927	7124
32343308	Negative_Correlation	MESH:D017409	MESH:D010146
32343308	Negative_Correlation	MESH:D020927	MESH:D004938
32343308	Negative_Correlation	MESH:D017409	MESH:D004938
32343308	Negative_Correlation	MESH:D020927	MESH:D007249
32343308	Negative_Correlation	MESH:D017409	3569

